184 related articles for article (PubMed ID: 17458610)
1. Impact of lymph node involvement on long-term survival after R0 pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas.
Zacharias T; Jaeck D; Oussoultzoglou E; Neuville A; Bachellier P
J Gastrointest Surg; 2007 Mar; 11(3):350-6. PubMed ID: 17458610
[TBL] [Abstract][Full Text] [Related]
2. Para-aortic lymph nodes and ductal adenocarcinoma of the pancreas: Distant neighbors?
Safi SA; Rehders A; Haeberle L; Fung S; Lehwald N; Esposito I; Ziayee F; Krieg A; Knoefel WT; Fluegen G
Surgery; 2021 Dec; 170(6):1807-1814. PubMed ID: 34392977
[TBL] [Abstract][Full Text] [Related]
3. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
4. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
5. [A result of surgical treatment for ductal adenocarcinoma of the head of the pancreas].
Moon HJ; Jang KT; Heo JS; Choi SH; Joh JW; Kim YI
Korean J Gastroenterol; 2003 Aug; 42(2):156-63. PubMed ID: 14532721
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival after resection of pancreatic ductal adenocarcinoma with para-aortic lymph node metastasis: case report.
Masui T; Kubota T; Aoki K; Nakanishi Y; Miyamoto T; Nagata J; Morino K; Fukugaki A; Takamura M; Sugimoto S; Onuma H; Tokuka A
World J Surg Oncol; 2013 Aug; 11(1):195. PubMed ID: 23945441
[TBL] [Abstract][Full Text] [Related]
7. Long-term survival after curative resection for pancreatic ductal adenocarcinoma--Surgical treatment.
Benassai G; Quarto G; Perrotta S; Furino E; Benassai GL; Amato B; Bianco T; De Palma G; Forestieri P
Int J Surg; 2015 Sep; 21 Suppl 1():S1-3. PubMed ID: 26118618
[TBL] [Abstract][Full Text] [Related]
8. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.
Pedrazzoli S; DiCarlo V; Dionigi R; Mosca F; Pederzoli P; Pasquali C; Klöppel G; Dhaene K; Michelassi F
Ann Surg; 1998 Oct; 228(4):508-17. PubMed ID: 9790340
[TBL] [Abstract][Full Text] [Related]
9. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.
Riediger H; Keck T; Wellner U; zur Hausen A; Adam U; Hopt UT; Makowiec F
J Gastrointest Surg; 2009 Jul; 13(7):1337-44. PubMed ID: 19418101
[TBL] [Abstract][Full Text] [Related]
10. Which patients with para-aortic lymph node (LN16) metastasis will truly benefit from curative pancreaticoduodenectomy for pancreatic head cancer?
Liu C; Lu Y; Luo G; Cheng H; Guo M; Liu Z; Xu J; Long J; Liu L; Fu D; Ni Q; Li M; Yu X
Oncotarget; 2016 May; 7(20):29177-86. PubMed ID: 27081079
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
Pawlik TM; Gleisner AL; Cameron JL; Winter JM; Assumpcao L; Lillemoe KD; Wolfgang C; Hruban RH; Schulick RD; Yeo CJ; Choti MA
Surgery; 2007 May; 141(5):610-8. PubMed ID: 17462460
[TBL] [Abstract][Full Text] [Related]
12. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience.
Richter A; Niedergethmann M; Sturm JW; Lorenz D; Post S; Trede M
World J Surg; 2003 Mar; 27(3):324-9. PubMed ID: 12607060
[TBL] [Abstract][Full Text] [Related]
14. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of para-aortic lymph node metastasis in pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Yuasa Y; Sueda T
World J Surg; 2010 Aug; 34(8):1900-7. PubMed ID: 20376442
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer.
Malleo G; Maggino L; Capelli P; Gulino F; Segattini S; Scarpa A; Bassi C; Butturini G; Salvia R
J Am Coll Surg; 2015 Aug; 221(2):367-79.e4. PubMed ID: 26081176
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
18. Severe postoperative complications decrease overall and disease free survival in pancreatic ductal adenocarcinoma after pancreaticoduodenectomy.
Lubrano J; Bachelier P; Paye F; Le Treut YP; Chiche L; Sa-Cunha A; Turrini O; Menahem B; Launoy G; Delpero JR
Eur J Surg Oncol; 2018 Jul; 44(7):1078-1082. PubMed ID: 29685757
[TBL] [Abstract][Full Text] [Related]
19. A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer.
Jang JY; Kang MJ; Heo JS; Choi SH; Choi DW; Park SJ; Han SS; Yoon DS; Yu HC; Kang KJ; Kim SG; Kim SW
Ann Surg; 2014 Apr; 259(4):656-64. PubMed ID: 24368638
[TBL] [Abstract][Full Text] [Related]
20. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]